Logo image of AXSM

AXSOME THERAPEUTICS INC (AXSM) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:AXSM - US05464T1043 - Common Stock

185.17 USD
-2.85 (-1.52%)
Last: 1/28/2026, 8:00:01 PM
185.17 USD
0 (0%)
After Hours: 1/28/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AXSM revenue by date.AXSM revenue by date.
50.04M270.6M
440.77%
385.693M
42.53%
645.76M
67.43%
1.021B
58.11%
1.569B
53.67%
2.063B
31.49%
2.679B
29.86%
3.175B
18.51%
3.252B
2.43%
3.585B
10.24%
3.847B
7.31%
EBITDA
YoY % growth
AXSM ebitda by date.AXSM ebitda by date.
-174.9M
-40.34%
-224.991M
-28.64%
-272.604M
-21.16%
-162.506M
40.39%
88.551M
154.49%
521.51M
488.94%
745.04M
42.86%
1.118B
50.06%
1.255B
12.25%
1.479B
17.85%
N/AN/A
EBIT
YoY % growth
AXSM ebit by date.AXSM ebit by date.
-179.3M
-43.77%
-231.825M
-29.29%
-280.562M
-21.02%
-153.032M
45.46%
69.41M
145.36%
549.22M
691.27%
869.02M
58.23%
1.435B
65.13%
1.827B
27.32%
1.929B
5.58%
1.908B
-1.09%
2.029B
6.34%
Operating Margin
AXSM operating margin by date.AXSM operating margin by date.
-358.31%-85.67%-72.74%-23.70%6.80%35.00%42.12%53.56%57.54%59.32%53.22%52.74%
EPS
YoY % growth
AXSM eps by date.AXSM eps by date.
-4.57
-31.70%
-5.20
-13.79%
-5.99
-15.19%
-3.72
37.85%
0.82
121.94%
9.12
1,016.96%
12.64
38.55%
19.49
54.20%
25.03
28.41%
21.98
-12.20%
24.06
9.49%
25.05
4.13%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.72
53.22%
-0.64
47.47%
-0.08
91.34%
0.39
141.29%
1.14
257.86%
1.60
349.88%
2.36
2,903.40%
3.10
698.95%
3.94
246.23%
Revenue
Q2Q % growth
195.25M
64.40%
194.89M
60.45%
235M
56.62%
273M
59.66%
320.63M
64.22%
367.7M
88.67%
428.93M
82.52%
486.54M
78.22%
549.6M
71.41%
EBITDA
Q2Q % growth
-33.582M
48.37%
-24.133M
57.77%
14.066M
143.50%
20.502M
152.14%
27.407M
181.61%
92.198M
482.04%
116.74M
729.94%
139.4M
579.93%
176.98M
545.75%
EBIT
Q2Q % growth
-34.234M
53.10%
-31.336M
47.14%
-1.897M
94.83%
29.831M
164.70%
74.975M
319.01%
92.198M
394.23%
116.74M
6,252.32%
139.4M
367.30%
176.98M
136.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.94
29.85%
-0.88-0.06-6.47%
Q2 2025
Q2Q % growth
-0.97
41.92%
-1.120.1513.31%
Q1 2025
Q2Q % growth
-1.22
15.28%
-1.350.139.80%
Q4 2024
Q2Q % growth
-1.54
25.96%
-1.04-0.50-48.67%
Q3 2024
Q2Q % growth
-1.34
-1.52%
-1.440.106.83%
Q2 2024
Q2Q % growth
-1.67
-8.44%
-1.36-0.31-22.89%
Q1 2024
Q2Q % growth
-1.44
-453.85%
-1.23-0.21-17.22%
Q4 2023
Q2Q % growth
-2.08
-47.52%
-1.19-0.89-74.11%
Q3 2023
Q2Q % growth
-1.32
-23.36%
-1.23-0.09-7.52%
Q2 2023
Q2Q % growth
-1.54
-45.28%
-1.25-0.29-23.51%
Q1 2023
Q2Q % growth
-0.26
74.76%
-1.060.8075.39%
Q4 2022
Q2Q % growth
-1.41
-56.67%
-1.16-0.25-21.43%
Q3 2022
Q2Q % growth
-1.07
-15.05%
-1.100.032.80%
Q2 2022
Q2Q % growth
-1.06
-23.26%
-1.230.1713.97%
Q1 2022
Q2Q % growth
-1.03
-32.05%
-1.02-0.01-0.75%
Q4 2021
Q2Q % growth
-0.90
-15.38%
-1.040.1413.63%
Q3 2021
Q2Q % growth
-0.93
-60.34%
-0.970.044.06%
Q2 2021
Q2Q % growth
-0.86
-75.51%
-0.980.1212.63%
Q1 2021
Q2Q % growth
-0.78
11.36%
-0.880.1011.84%
Q4 2020
Q2Q % growth
-0.78 -0.77-0.01-0.90%
Q3 2020
Q2Q % growth
-0.58 -0.580.000.62%
Q2 2020
Q2Q % growth
-0.49 -0.630.1422.07%
Q1 2020
Q2Q % growth
-0.88 -0.64-0.24-38.16%
AXSM Yearly EPS VS EstimatesAXSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
170.992M
63.22%
165.8M5.192M3.13%
Q2 2025
Q2Q % growth
150.042M
72.13%
141.54M8.502M6.01%
Q1 2025
Q2Q % growth
121.463M
61.95%
122.26M-797K-0.65%
Q4 2024
Q2Q % growth
118.766M
66.03%
120M-1.234M-1.03%
Q3 2024
Q2Q % growth
104.762M
81.27%
100.94M3.822M3.79%
Q2 2024
Q2Q % growth
87.166M
89.42%
88.66M-1.494M-1.69%
Q1 2024
Q2Q % growth
74.999M
-20.70%
74.761M238K0.32%
Q4 2023
Q2Q % growth
71.531M
193.52%
68.915M2.616M3.80%
Q3 2023
Q2Q % growth
57.794M
242.99%
55.959M1.835M3.28%
Q2 2023
Q2Q % growth
46.017M
421.73%
41.753M4.264M10.21%
Q1 2023
Q2Q % growth
94.576M 26.591M67.985M255.67%
Q4 2022
Q2Q % growth
24.37M 22.195M2.175M9.80%
Q3 2022
Q2Q % growth
16.85M 16.968M-118K-0.70%
Q2 2022
Q2Q % growth
8.82M 6.418M2.402M37.43%
AXSM Yearly Revenue VS EstimatesAXSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-50.68% -10.77% 0.11% -0.93%
Revenue1.98% 3.22% 0.62% 2.24%